Form D · Pharmaceuticals
SOLAEROMED INC.
Calgary, A0 · CIK 0001589969
Offering snapshot reported Nov 25, 2013 · SEC filing
- Reported sold
- $101K Offering amount: $101K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 20, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 25, 2013 | Initial | $101,035 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 04, 05, 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-206960
US dollar equivalent of Canadian $106,500.
Source: Form D, filed Nov 25, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Andy Clark | Director |
| John Dennis | Executive |
| Michael Peter Flach | Director |
| Francis Green | Director |
| Gwyn Humphreys | Director |
| Phyllis Kane, | Director |
| Ian Mcaffer | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
3535 Research Road N.W.
Calgary, A0, R2L 2K8
Calgary, A0, R2L 2K8